Fusion Fund
Fusion Fund is a Palo Alto, California-based venture capital firm that targets early-stage technology companies across the United States and Canada. The firm typically backs pre-seed, seed, and Series A rounds and focuses on sectors including healthcare technology, enterprise AI, industrial technology, information technology, and complementary areas such as the Internet of Things, robotics and drones, cybersecurity, and blockchain. It emphasizes backing companies with strong technical barriers and defensible advantages capable of global disruption, leveraging a blend of technical and entrepreneurial expertise to support founders aiming for scalable growth.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Pennsylvania
Proscia
Series D in 2025
Proscia Inc., established in 2014 and headquartered in Philadelphia, Pennsylvania, specializes in digital pathology informatics through its innovative cloud-based platform. This platform aids in routine pathology operations, enhances cancer diagnosis, and seeks to improve patient outcomes. By leveraging advanced computing technologies, Proscia's solution unlocks hidden data that is not discernible to the human eye, transforming that information into valuable insights. These insights support physicians in accelerating the development of life-saving medical advances, ultimately contributing to a more effective diagnostic process in the field of pathology.
Proscia
Series C in 2024
Proscia Inc., established in 2014 and headquartered in Philadelphia, Pennsylvania, specializes in digital pathology informatics through its innovative cloud-based platform. This platform aids in routine pathology operations, enhances cancer diagnosis, and seeks to improve patient outcomes. By leveraging advanced computing technologies, Proscia's solution unlocks hidden data that is not discernible to the human eye, transforming that information into valuable insights. These insights support physicians in accelerating the development of life-saving medical advances, ultimately contributing to a more effective diagnostic process in the field of pathology.
Locomation
Seed Round in 2020
Locomation develops an AI-driven trucking technology platform that combines autonomy with driver augmentation. Its Autonomous Relay Convoy system enables trucks to follow a lead vehicle autonomously, enhancing safety and efficiency while reducing operational costs.
Locomation
Venture Round in 2020
Locomation develops an AI-driven trucking technology platform that combines autonomy with driver augmentation. Its Autonomous Relay Convoy system enables trucks to follow a lead vehicle autonomously, enhancing safety and efficiency while reducing operational costs.
Proscia
Series A in 2018
Proscia Inc., established in 2014 and headquartered in Philadelphia, Pennsylvania, specializes in digital pathology informatics through its innovative cloud-based platform. This platform aids in routine pathology operations, enhances cancer diagnosis, and seeks to improve patient outcomes. By leveraging advanced computing technologies, Proscia's solution unlocks hidden data that is not discernible to the human eye, transforming that information into valuable insights. These insights support physicians in accelerating the development of life-saving medical advances, ultimately contributing to a more effective diagnostic process in the field of pathology.
Locomation
Seed Round in 2018
Locomation develops an AI-driven trucking technology platform that combines autonomy with driver augmentation. Its Autonomous Relay Convoy system enables trucks to follow a lead vehicle autonomously, enhancing safety and efficiency while reducing operational costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.